Trident Lifeline Ltd. manufactures and markets pharmaceutical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2022-10-10. The firm is also engaged in distribution of pharmaceutical products through a third party distribution network. The company offers a range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. The company deals in capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders and toothpaste. Its product portfolio includes a range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozoal, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nutraceutical and Non-steroidal anti-inflammatory drug (NSAIDS). Its product portfolio consists of approximately 832 products. The company operates in India, as well as African, Latin American and East Indian countries.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.